Primary cardiac hydatid cyst presenting with massive pericardial effusion: a case report

Badre El Boussaadani1,2, Hind Regragui3,4, Hanae Bouhdadi2,5

  • 1Cardiology B Department, Ibn Sina University Hospital Center, Rabat, Morocco.

Insights

This case report highlights a rare primary pericardial hydatid cyst, emphasizing the importance of considering cardiac hydatidosis in endemic areas. Prompt diagnosis and combined surgical and medical treatment are crucial for favorable outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Parasitology

Background:

  • Cardiac hydatidosis, a rare manifestation of Echinococcus infection, accounts for 0.5-2% of hydatid disease.
  • While typically affecting the left ventricle myocardium, it can involve other cardiac structures, including the pericardium.
  • Clinical presentations range from asymptomatic to severe conditions like cardiogenic shock and sudden death.

Purpose of the Study:

  • To report an exceptional case of primary pericardial hydatid cyst.
  • To emphasize the diagnostic challenges and potential life-threatening complications of this rare cardiac hydatidosis localization.
  • To guide the clinical management of cardiac hydatid cysts, particularly in the presence of pericardial effusion.

Main Methods:

  • A case of a 70-year-old woman with dyspnea and right heart failure due to a ruptured primary pericardial hydatid cyst is presented.
  • Diagnosis was confirmed using echocardiography, computed tomography (CT) scan, and hydatid serology.
  • The patient underwent surgical intervention and a 3-month course of albendazole.

Main Results:

  • The patient presented with dyspnea (NYHA class IV) and signs of right heart failure, with a ruptured pericardial hydatid cyst and pre-tamponade.
  • Diagnostic imaging and serology confirmed the diagnosis.
  • Post-operative treatment with albendazole resulted in a favorable clinical course.

Conclusions:

  • Cardiac hydatid cysts should be considered in cases of pericardial effusion, especially with a history of hydatid disease, animal contact, or in endemic regions.
  • Accurate differential diagnosis using cardiac imaging is essential to avoid complications.
  • Management requires a combined approach of surgery and antiparasitic medication (albendazole or mebendazole).
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
242
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
189
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
175
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
288
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
167
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
185